Redigerer Convidecia

[[File:CanSino Convidecia.jpg|right|thumb|Multidose hetteglass med [[CanSino Biologics]]' Convidecia-vaksine (AD5-nCOV) på flaske i Mexico.]]
'''AD5-nCOV''', solgt som '''Convidecia''', er en enkeltdoses<ref name=":22">{{Cite web|title=It's not just Johnson & Johnson: China has a single-dose COVID-19 vaccine that's 65% effective|url=https://fortune.com/2021/02/09/china-covid-vaccine-single-dose-cansino-johnson-johnson/|access-date=2021-02-11|website=Fortune}}</ref> [[viral vektor]]-[[vaksine]] mot [[SARS-CoV-2]], viruset som forårsaker [[covid-19]]. Den er utviklet av det kinesiske foretaket [[CanSino Biologics]]. 

Siden sent i 2020 har den vært i Fase III-utprøving i [[Argentina]],<ref name=":0">{{cite web|date = 14. desember 2020 |title=Comenzará en la Argentina un nuevo estudio de vacuna recombinante contra el SARS-CoV-2|url=https://www.infobae.com/america/tendencias-america/2020/12/14/comenzara-en-la-argentina-un-nuevo-estudio-de-vacuna-recombinante-contra-el-sars-cov-2/|access-date=2020-12-15|website=infobae|language=es-ES}}</ref> [[Chile]],<ref name=":9">{{cite web |title=Gob.cl - Article: Science Minister: "We Work With Maximum Rigor So That Science And Technology Benefit People'S Health"|url=https://www.gob.cl/en/news/science-minister-we-work-with-maximum-rigor-so-that-science-and-technology-benefit-peoples-health/|access-date=2020-11-21|website=Government of Chile}}</ref> [[Mexico]],<ref name=":10">{{cite web|date=2020-11-10|title=Chinese Covid vaccine trials to be expanded to five more states|url=https://mexiconewsdaily.com/news/chinese-covid-vaccine-trials-to-be-expanded-to-five-more-states/|access-date=2020-11-11|website=Mexico News Daily}}</ref> [[Pakistan]],<ref name=":1">{{cite web|title=Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above - Full Text View - ClinicalTrials.gov|url=https://clinicaltrials.gov/ct2/show/NCT04526990|access-date=2020-10-21|website=clinicaltrials.gov}}</ref> [[Russland]]<ref name=":11">{{cite news|author=Reuters Staff|date=2020-12-07|title=Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax|work=Reuters|url=https://ca.reuters.com/article/us-health-coronavirus-china-russia-idUSKBN28H0RN|access-date=2020-12-07|accessdate=2021-04-03|archivedate=2020-12-09|archiveurl=https://web.archive.org/web/20201209075227/https://ca.reuters.com/article/us-health-coronavirus-china-russia-idUSKBN28H0RN|url-status=yes}}</ref> og [[Saudi-Arabia]]<ref name=":12">{{cite news| vauthors = Eltahir N |url=https://www.reuters.com/article/us-health-coronavirus-saudi-cansinobio/cansino-to-start-phase-iii-trial-of-covid-19-vaccine-in-saudi-idUSKCN2550L9|title=CanSino to start Phase III trial of COVID-19 vaccine in Saudi|work=Reuters|date=9. august 2020|access-date=9. august 2020}}</ref> med 40.000 deltakere.

I februar 2021 viste globale data fra Fase III og 101 covidtilfeller at vaksinen hadde en 65,7% effektivitet mot å hindre moderate symptomer av covid-19, og 91% effektivitet til å forhindre alvorlig sykdom.<ref name=":82">{{Cite web|date=8. februar 2021|title=CanSinoBIO's COVID-19 vaccine 65.7% effective in global trials, Pakistan official says|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-pakistan/cansinobios-covid-19-vaccine-657-effective-in-global-trials-pakistan-official-says-idUSKBN2A81N0|access-date=2021-02-08|publisher=[[Reuters]]}}</ref> Dette var funn som lignet på dem angjeldende [[Johnson & Johnson]]s [[Johnson & Johnson COVID-19-vaksine|Ad26.COV2.S]], en annen endoses adenovirus vektorvaksine med 66% effekt i en global utprøving.<ref name=":72">{{Cite news|date=2021-02-08|title=China's CanSino Covid Vaccine Shows 65.7% Efficacy|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-02-08/pakistan-says-cansino-s-covid-vaccine-shows-65-7-efficacy|access-date=2021-02-10}}</ref><ref name=":22" /> Convidecia ligner på andre viral vektor-vaksiner som [[Oxford–AstraZeneca COVID-19-vaksine|AZD1222]], [[Sputnik V COVID-19-vaksine|Gam-COVID-Vac]] og [[Johnson & Johnson COVID-19-vaksine|Ad26.COV2.S]].<ref name=":32">{{cite news|date=2020-06-10|title=Coronavirus Vaccine Tracker|work=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=2020-12-12|issn=0362-4331|vauthors=Zimmer C, Corum J, Wee SL}}</ref> At den er en endosevaksine som kan lagres i normal kjøleskaptemperatur (2°til 8&nbsp;°C) kunne gjøre den anvendbar i mange land.<ref name=":72" />

Convidecia er autorisert for bruk i Kina,<ref name=":13">{{Cite news|last=Staff|first=Reuters|date=2021-02-25|title=China approves two more domestic COVID-19 vaccines for public use|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW|access-date=2021-02-26}}</ref> Mexico,<ref name=":14">{{cite news|date=10. februar 2021|title=Mexico approves China's CanSino and Sinovac COVID-19 vaccines|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-mexico-cansino/update-2-mexico-approves-chinas-cansino-and-sinovac-covid-19-vaccines-idUSL1N2KG0NO}}</ref> Pakistan<ref name=":15">{{Cite news|last=Shahzad|first=Asif|date=2021-02-12|title=Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine-idUSKBN2AC1FG|access-date=2021-02-12}}</ref> og Ungarn.<ref>{{cite web | title=China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary | website=MSN | date=22. mars 2021 | url=https://www.msn.com/en-xl/europe/top-stories/china-s-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-in-hungary/ar-BB1eOIEV | access-date=22. mars 2021}}</ref> Produksjonskapasiteten for Ad5-NCov skulle kunne nå opp til 500 millioner doser i 2021.<ref name=":16">{{Cite web|title=China can hit 500-mln-dose annual capacity of CanSinoBIO COVID-19 vaccine this year|url=https://finance.yahoo.com/news/china-hit-500-mln-dose-103509138.html|url-status=live|access-date=2021-02-28|website=finance.yahoo.com}}</ref>
==Referanser==
<references/>

[[Kategori:Covid-19-vaksiner]]
[[Kategori:Koronavirus vaksinearbeid]]